|
PDE6D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99507077525141E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32220001614058E-09 |
| Normal-vs-Stage2 |
1.343110E-03 |
| Normal-vs-Stage3 |
1.70941039101535E-12 |
| Normal-vs-Stage4 |
3.37800000194122E-08 |
| Stage1-vs-Stage2 |
8.251000E-01 |
| Stage1-vs-Stage3 |
2.757900E-03 |
| Stage1-vs-Stage4 |
1.182640E-01 |
| Stage2-vs-Stage3 |
3.548100E-02 |
| Stage2-vs-Stage4 |
2.017800E-01 |
| Stage3-vs-Stage4 |
5.048800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12352357920054E-12 |
| Normal-vs-AfricanAmerican |
2.600300E-03 |
| Normal-vs-Asian |
2.65720000003355E-06 |
| Caucasian-vs-AfricanAmerican |
4.855400E-01 |
| Caucasian-vs-Asian |
5.385400E-01 |
| AfricanAmerican-vs-Asian |
8.163400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.12199999963347E-07 |
| Normal-vs-Female |
5.20694598549198E-13 |
| Male-vs-Female |
1.462360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05030000252526E-08 |
| Normal-vs-Age(41-60Yrs) |
1.65545355201857E-12 |
| Normal-vs-Age(61-80Yrs) |
4.34069999999398E-06 |
| Normal-vs-Age(81-100Yrs) |
1.936040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.145660E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.777000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.196000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.092000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.391200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.514570E-01 |
| Classical-VS-Follicular |
2.424700E-03 |
| Classical-VS-Other |
4.266000E-01 |
| Classical-VS-Normal |
2.99860136721009E-11 |
| Tall-VS-Follicular |
3.964800E-03 |
| Tall-VS-Other |
1.599420E-01 |
| Tall-VS-Normal |
1.19140000087725E-08 |
| Follicular-VS-Other |
7.415200E-01 |
| Follicular-VS-Normal |
1.349600E-02 |
| Other-VS-Normal |
2.107000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92299998147405E-09 |
| Normal-vs-N1 |
2.6098999994506E-07 |
| N0-vs-N1 |
3.085400E-01 |
|
|
